annexin pharmaceuticals annexin pharmaceuticals annexin pharmaceuticals is a swedish privately held biotech company developing new therapeutic approaches for inflammatory cardiovascular diseases. the concept for the therapy is based on the anti-inflammatory properties of annexin a5, a body own protective protein that acts simultaneously against several key pathogenic mechanisms of cardiovascular diseases. the company is currently focusing on treatment of peripheral artery disease (pad).